Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Working Capital/Sales

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 4.374.252.102.142.50

What is the latest Working Capital/Sales ratio of AJANTA PHARMA ?

The latest Working Capital/Sales ratio of AJANTA PHARMA is 4.37 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20244.37
Mar20234.25
Mar20222.10
Mar20212.14
Mar20202.50

How is Working Capital/Sales of AJANTA PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 4.37
2.82
Mar2023 4.25
102.38
Mar2022 2.1
-1.87
Mar2021 2.14
-14.40
Mar2020 2.5 -

Other Financial Ratios of AJANTA PHARMA


Compare Working Capital/Sales ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,479.1 Cr -4.2% -2.5% 44.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,948.0 Cr 0.3% 0.2% 46% Stock Analytics
DIVIS LABORATORIES ₹157,873.0 Cr -2.7% -0.1% 58.9% Stock Analytics
CIPLA ₹116,809.0 Cr -3% -8.6% 19% Stock Analytics
DR REDDYS LABORATORIES ₹103,963.0 Cr -0.1% -3.4% 7.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,173.2 Cr 0.8% 1.8% 48.1% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-4.2%

-2.5%

44.1%

SENSEX

-0.6%

2.3%

16.9%


You may also like the below Video Courses